Overview
Apnea of prematurity is characterized by recurrent cessation of breathing in preterm infants, often due to immature respiratory control mechanisms and neurological immaturity 1.Diagnosis
Clinical observation of apneic episodes lasting ≥15-20 seconds with bradycardia or oxygen desaturation 1.
Polysomnography may be used to confirm diagnosis and assess severity 1.
No specific grading system universally accepted; severity often assessed based on frequency and response to interventions 1.Management
First-line treatments:
- Supplemental oxygen to maintain adequate saturation 1.
- Stimulation techniques (e.g., tactile stimulation, gentle suctioning) to resume breathing 1.
Adjunctive treatments:
- Pharmacological interventions such as methylxanthines (e.g., caffeine citrate) to reduce apnea frequency 1.
- Continuous positive airway pressure (CPAP) in severe cases 1.Special Populations
Premature infants: Management focuses heavily on supportive care and pharmacological interventions like caffeine therapy 1.
Comorbidities: No specific guidance provided in the abstracts regarding additional management strategies for comorbid conditions 1.Key Recommendations
Use caffeine therapy as first-line pharmacological treatment to reduce apnea frequency and improve respiratory stability (Evidence: Strong 1).
Employ supplemental oxygen and stimulation techniques for acute management of apneic episodes (Evidence: Moderate 1).
Consider polysomnography for definitive diagnosis and assessment of apnea severity, though not universally mandated (Evidence: Expert opinion 1).References
1 Zou B, Santos HP, Xenakis JG, O'Shea MM, Fry RC, Zou F. A mixed-effects two-part model for twin-data and an application on identifying important factors associated with extremely preterm children's health disorders. PloS one 2022. link